1. Home
  2. PROF vs EARN Comparison

PROF vs EARN Comparison

Compare PROF & EARN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PROF
  • EARN
  • Stock Information
  • Founded
  • PROF N/A
  • EARN 2012
  • Country
  • PROF Canada
  • EARN United States
  • Employees
  • PROF N/A
  • EARN N/A
  • Industry
  • PROF Medical/Dental Instruments
  • EARN Real Estate Investment Trusts
  • Sector
  • PROF Health Care
  • EARN Real Estate
  • Exchange
  • PROF Nasdaq
  • EARN Nasdaq
  • Market Cap
  • PROF 164.4M
  • EARN 187.6M
  • IPO Year
  • PROF N/A
  • EARN 2013
  • Fundamental
  • Price
  • PROF $4.27
  • EARN $5.60
  • Analyst Decision
  • PROF Strong Buy
  • EARN Buy
  • Analyst Count
  • PROF 2
  • EARN 2
  • Target Price
  • PROF $11.50
  • EARN $5.88
  • AVG Volume (30 Days)
  • PROF 79.0K
  • EARN 424.6K
  • Earning Date
  • PROF 05-08-2025
  • EARN 05-20-2025
  • Dividend Yield
  • PROF N/A
  • EARN 17.14%
  • EPS Growth
  • PROF N/A
  • EARN N/A
  • EPS
  • PROF N/A
  • EARN 0.28
  • Revenue
  • PROF $11,862,000.00
  • EARN $41,240,000.00
  • Revenue This Year
  • PROF $71.17
  • EARN N/A
  • Revenue Next Year
  • PROF $134.25
  • EARN $16.66
  • P/E Ratio
  • PROF N/A
  • EARN $20.05
  • Revenue Growth
  • PROF 75.01
  • EARN N/A
  • 52 Week Low
  • PROF $3.90
  • EARN $4.33
  • 52 Week High
  • PROF $11.42
  • EARN $7.26
  • Technical
  • Relative Strength Index (RSI)
  • PROF 34.68
  • EARN 57.07
  • Support Level
  • PROF $4.62
  • EARN $5.33
  • Resistance Level
  • PROF $5.62
  • EARN $5.72
  • Average True Range (ATR)
  • PROF 0.42
  • EARN 0.12
  • MACD
  • PROF -0.01
  • EARN 0.03
  • Stochastic Oscillator
  • PROF 8.45
  • EARN 73.91

About PROF Profound Medical Corp.

Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.

About EARN Ellington Residential Mortgage REIT of Beneficial Interest

Ellington Credit Co is focused on corporate collateralized loan obligations (CLOs). It focuses on acquiring, investing in, and managing secondary CLO mezzanine debt and equity tranches. The company relies on strong risk management, including disciplined liquidity management and selective use of credit hedges, to preserve book value during times of stress. It also leverages Ellington's proprietary technology, analytics and risk management systems to enhance underwriting and investment selection and to guide ongoing portfolio monitoring and surveillance.

Share on Social Networks: